Statistics

Total Visits

Views
Lapatinib vs trastuzumab in combination with standard EC-D chemotherapy in the neaodjuvant treatment of HER2+ patients. Results from the GEICAM 2006-14 phase II randomized trial62

Select a period of time:

Number of views in the range

Views
Lapatinib vs trastuzumab in combination with standard EC-D chemotherapy in the neaodjuvant treatment of HER2+ patients. Results from the GEICAM 2006-14 phase II randomized trial47

Views

Views
March 202517
April 20252
May 20250
June 20250
July 202527
August 20250
September 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore17
United States12
Brazil7
Mexico3
Kenya2
Argentina1
Colombia1
Spain1
United Kingdom1
Morocco1
 

Top cities views

Views
São Paulo2
Acapulco de Juárez1
Benton1
Bogotá1
Caracas1
Chicago1
Clark1
Corumbá1
Council Bluffs1
Curitiba1